ANTICUERPOS IL-25 HUMANIZADOS

La presente invención se refiere a miembros de unión al objetivo (por ejemplo, anticuerpos) que se unen a un epítopo específico de la IL-25 humana. The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to t...

Full description

Saved in:
Bibliographic Details
Main Authors BRANIGAN, PATRICK, TORNETTA, MARK, KANE, COLLEEN, TAUDTE, SUSANN, WHEELER, JOHN, ALMAGRO, JUAN, CARLOS, STROHL, WILLIAM
Format Patent
LanguageSpanish
Published 15.05.2013
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:La presente invención se refiere a miembros de unión al objetivo (por ejemplo, anticuerpos) que se unen a un epítopo específico de la IL-25 humana. The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).
Bibliography:Application Number: CR20120000553